EEDi-5273
N/A
Report date: 2023/01/13 14:43:47
NME
Base Information
Drug NameEEDi-5273
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesUniversity Of MichiganJiangsu Ascentage Pharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesAscentage Pharma Group InternationalAscentage Pharma Group IncSuzhou Ascentage Pharma Co Ltd +[4]
Inactive CompaniesUniversity Of MichiganJiangsu Ascentage Pharma Co Ltd
Active Indications +[12]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A